SCHEMBL21361152

SCHEMBL21361152

COC(=O)C(CO)NC(=O)CCCCC1SCC2NC(O)NC21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 5/20 0.42
▸ CNR1 P21554 3/20 0.38
▸ MEN1 O00255 1/20 0.35
▸ ABL1 P00519 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ IDE P14735 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ RIN1 Q13671 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ FOLH1 Q04609 2/20 0.34
▸ CAPN1 P07384 2/20 0.34
▸ CNR2 P34972 2/20 0.34
▸ PLG P00747 1/20 0.33
▸ PRSS1 P07477 1/20 0.33
▸ PRSS2 P07478 1/20 0.33
▸ PRSS3 P35030 1/20 0.33
▸ TPSAB1 Q15661 1/20 0.33
▸ CA12 O43570 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11974139 0.91 TDP1 (0.36) TDP1CNR1FOLH1CAPN1CNR2
SCHEMBL21390226 0.79 TDP1 (0.44) TDP1MEN1ABL1LMNAPKM
SCHEMBL11983829 0.78 TDP1 (0.42) TDP1CNR1FOLH1CAPN1CNR2
SCHEMBL11983709 0.77 CNR1 (0.43) TDP1CNR1FOLH1CAPN1CNR2
SCHEMBL21206321 0.77 PRSS1 (0.47) TDP1CNR1MEN1ABL1LMNA
SCHEMBL21361153 0.77 TDP1 (0.62) TDP1CNR1MEN1ABL1LMNA
SCHEMBL22473613 0.76 FAAH (0.42) TDP1CNR1MEN1ABL1LMNA
SCHEMBL11974137 0.76 TDP1 (0.35) TDP1CNR1FOLH1PRSS1PRSS2
SCHEMBL19034456 0.75 TDP1 (0.45) TDP1CNR1MEN1ABL1LMNA
SCHEMBL20342144 0.75 TDP1 (0.45) TDP1MEN1ABL1LMNAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10413621-B2 Composition and methods for imaging cells CASE WESTERN RESERVE UNIVERSITY (US) 2019-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10413621-B2 Composition and methods for imaging cells MCL1, TP53, HNRNPAB TDP1 3017/4885CNR1 2138/4885MEN1 413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback